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Letters to the Editor
Letters to the Editor will be published, if suitable, as space permits. They should not exceed 500 words
(typed double-spaced) in length and may be subject to editing or abridgment.
Is QT Interval Prolongation a Strong or a Weak
Predictor for Cardiac Death?
In Ahnve's Editorial Comment in Circulation, ' based in part on
our own papers,23 he discusses the prognostic value of QT,
prolongation. We agree with his conclusion that QT, duration of
>440 msec is associated with increased risk for cardiac death.
However, we would like to draw attention to the observed
difference between men and women.
Among women, the prevalence of QT, prolongation is two to
three times higher than among men.2-6 However, we found that
QT, of >440 msec is much less predictive of coronary heart
disease mortality or sudden death in women than in men. In the
28-year follow-up study of >3,000 civil servants, men with QT, of
2440 msec had twice the risk of coronary heart disease mortality
as men with QT, of <420 msec. Among women, the relative risk
was only 1.1.2 The risk for cardiovascular disease mortality was
somewhat higher but not significant. Choosing a cut off of 450 or
460 msec did not make any difference. The discrepancy also was
reported in the 2-year follow-up study among 6,693 patients who
had 24-hour ambulatory ECG. Men with QT, of >440 msec had a
relative risk of sudden death of 3.3 compared with men with QT,
<440 msec. For women, the relative risk was 1.7.3
The association between QT, duration and cardiac death clearly
seems to vary by sex. Of course, this implies that data from men
and women should be processed and reported separately. If not,
the increased risk among men may be obscured. In studies in
which women make up a large part of the prolonged QT, catego-
ry,5 this may have diluted the relative risks reported. Most
previous studies did not report results for men and women
separately. Some did not describe the sex distribution of the
subjects either.
Several other ECG characteristics have proved to be different
between men and women.78 What causes these differences be-
tween men and women? It might be the smaller size of the female
heart or some effect of hormonal differences or of the autonomic
regulation of the heart. This may be an interesting topic for future
physiological and ECG studies. Whatever the physiological back-
ground, the sex discrepancy should be taken into consideration in
the analysis and interpretation of ECG data.
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Joint Effects of Serum Triglycerides and LDL and
HDL Cholesterol
In a further analysis of the Helsinki Heart Study, Manninen et
all have attempted to elucidate the troublesome relation between
serum triglyceride levels and coronary heart disease. Although
their analysis is intriguing, several problems remain.
First, and most importantly, we should be cautious about
implications for drug treatment in populations of people who do
not have clinical disease. As the authors note, there was no
significant decrease in all-cause mortality in the gemfibrozil-
treated group, even in the highest-risk stratum. In fact, when data
from the first 1.5 years of poststudy follow-up are included, there
was an almost significant increase in noncardiac deaths in the
treatment group (43 versus 27, p=0.056) and no significant differ-
ence in total mortality overall (59 versus 55, p=O0.7).2 Data from 2
more years of follow-up presented at the NIH Conference on HDL
and Triglycerides (Bethesda, Md., February 26-28, 1992) revealed
a trend toward increasing total mortality in the gemfibrozil group,
with 101 deaths in the treatment arm versus 83 deaths in the
placebo arm (p=0.16). This information, combined with other
recent data,3 raises further questions about the wisdom of drug
treatment for altering blood lipids in otherwise healthy
individuals.
Second, although a stratified analysis avoids the modeling
assumptions of regression analysis, it does not fully "eliminate the
effects of multicollinearity." When subsamples defined by high
density lipoprotein (HDL) levels (or the ratio of low density
lipoprotein [LDL] to HDL) are again stratified by triglyceride
levels, the result is four strata that differ in levels of HDL, since
stratification does not eliminate the correlation between triglycer-
ide and HDL. That is, the highest-risk group in the article's Figure
3, defined by the combination of a low HDL/LDL ratio and a high
triglyceride level, is also unique in having the lowest mean HDL
level of the four strata. This fact is verified by reference to Table
7, which reveals a monotonic increase in the proportion of subjects
in the lowest tertile of HDL.
Third, an analysis of the heterogeneity of the odds ratios does
not support the presence of a statistically significant interaction.
Using the data from Figure 3 and Table 6, we performed a X2 test
for interaction that yielded a value ofp=0.22. The authors should
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